E-LIB Suche - Ergebnisse für: Abou-Alfa, Ghassan

1

Dermatologic Adverse Events Associated with Selective Fibro..:

Lacouture, Mario E. ; Sibaud, Vincent ; Anadkat, Milan J....
The Oncologist. 26 (2020) 2 - p. e316-e326 , 2020

Link: https://doi.org/10.1002/..

2

Patient advocacy and the future of systemic therapies in li..:

Abou-Alfa, Ghassan
Hepatic Oncology. 7 (2020) 1 - p. , 2020

Link: https://doi.org/10.2217/..

3

Gastrointestinal Cancer Educatinal Case Series: A 65 year-o..:

Smyth, Elizabeth C. ; Lee, Yeon Jou ; Abou-Alfa, Ghassan...
Journal of Gastrointestinal Cancer. 43 (2011) 1 - p. 93-96 , 2011

Link: https://doi.org/10.1007/..

4

Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Ch..:

Thomas, Melanie B. ; O'Beirne, James P. ; Furuse, Junji...
Annals of Surgical Oncology. 15 (2008) 4 - p. 1008-1014 , 2008

Link: https://doi.org/10.1245/..

5

Safety and feasibility of Preoperative Simultaneous Portal ..:

Yarmohammadi, Hooman ; Jarnagin, William ; Soares, Kevin C....
Current Cancer Reports. 5 (2024) - p. 160-167 , 2024

Link: https://doi.org/10.25082..

6

Cardiovascular implications of anti-angiogenic therapeutic ..:

Al Mahmasani, Layal ; Abou-Alfa, Ghassan K.
American Heart Journal Plus: Cardiology Research and Practice. 43 (2024) - p. 100406 , 2024

Link: https://doi.org/10.1016/..

7

CALGB 80802 (Alliance): Impact of Sorafenib with and withou..:

Abou-Alfa, Ghassan K. ; Geyer, Susan M. ; Nixon, Andrew B....
Cancer Research Communications. 4 (2024) 3 - p. 682-690 , 2024

Link: https://doi.org/10.1158/..

8

Botensilimab plus balstilimab in relapsed/refractory micros..:

Bullock, Andrea J. ; Schlechter, Benjamin L. ; Fakih, Marwan G....
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

9

Pharmacokinetics/pharmacodynamics of ivosidenib in advanced..:

Fan, Bin ; Abou-Alfa, Ghassan K. ; Zhu, Andrew X....
Cancer Chemotherapy and Pharmacology. 93 (2024) 5 - p. 471-479 , 2024

Link: https://doi.org/10.1007/..

10

Clinicogenomic predictors of outcomes in patients with hepa..:

Cowzer, Darren ; Chou, Joanne F ; Walch, Henry...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

11

Plain language summary of the HIMALAYA study: tremelimumab ..:

Abou-Alfa, Ghassan K ; Lau, George ; Kudo, Masatoshi...
Future Oncology. 19 (2023) 38 - p. 2505-2516 , 2023

Link: https://doi.org/10.2217/..

12

MEK Inhibitor-Associated Ocular Hypertension:

Collet, David A. ; Canestraro, Julia ; Abou-Alfa, Ghassan K....
Ocular Oncology and Pathology. 10 (2023) 2 - p. 98-102 , 2023

Link: https://doi.org/10.1159/..

13

Health diplomacy in action: The cancer legacy of the Good F..:

Lawler, Mark ; Sullivan, Richard ; Abou-Alfa, Ghassan K....
Journal of Cancer Policy. 38 (2023) - p. 100448 , 2023

Link: https://doi.org/10.1016/..

14

Defining incidence and complications of fibrolamellar liver..:

Zack, Travis ; Losert, Kurt P. ; Maisel, Samantha M....
npj Precision Oncology. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

15

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J. ; Piha-Paul, Sarina A. ; Shah, Ronak H....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..